RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
-11.65%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$782M
AUM Growth
+$782M
(-23%)
Cap. Flow
+$36.7M
Cap. Flow
% of AUM
4.69%
Top 10 Holdings %
Top 10 Hldgs %
64.89%
Holding
44
New
7
Increased
12
Reduced
6
Closed
2
Top Buys
| 1 |
Nektar Therapeutics
NKTR
|
$43.7M |
| 2 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$37.1M |
| 3 |
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
|
$15.6M |
| 4 |
TG Therapeutics
TGTX
|
$14.6M |
| 5 |
Ardelyx
ARDX
|
$13.4M |
Top Sells
| 1 |
DYAX
DYAX CORPORATION
DYAX
|
$102M |
| 2 |
RGLS
Regulus Therapeutics
RGLS
|
$16.9M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$14.8M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$14.8M |
| 5 |
Collegium Pharmaceutical
COLL
|
$6.74M |
Sector Composition
| 1 | Healthcare | 91.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Wave Life Sciences
WVE
$1.53B
| $98.4M | 12.58% | 7,088,651 | – | – |
|
|
ACHN
2
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $92.9M | 11.87% | 12,033,220 +810,327 | +7% | +$6.26M |
|
|
SIOX
3
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $57.4M | 7.34% | 5,000,000 | – | – |
|
4
Aclaris Therapeutics
ACRS
$209M
| $49.8M | 6.36% | 2,627,719 +63,166 | +2% | +$1.2M |
|
|
5
Nektar Therapeutics
NKTR
$568M
| $43.7M | 5.59% | +3,178,854 | New | +$43.7M |
|
6
Ascendis Pharma
ASND
$11.8B
| $40.1M | 5.12% | 2,161,366 +489,919 | +29% | +$9.09M |
|
|
7
TG Therapeutics
TGTX
$4.65B
| $38.6M | 4.94% | 4,531,714 +1,717,935 | +61% | +$14.6M |
|
|
AVXS
8
DELISTED
AveXis, Inc. Common Stock
AVXS
| $37.1M | 4.74% | +1,361,582 | New | +$37.1M |
|
9
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $27M | 3.45% | 1,272,048 | – | – |
|
|
ZGNX
10
DELISTED
Zogenix, Inc.
ZGNX
| $22.6M | 2.9% | 2,451,237 +198,000 | +9% | +$1.83M |
|
|
ARNA
11
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $18.4M | 2.36% | 9,364,105 +649,623 | +7% | +$1.28M |
|
|
12
Ardelyx
ARDX
$1.53B
| $17.9M | 2.28% | 2,300,481 +1,729,037 | +303% | +$13.4M |
|
|
AIMT
13
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $17.5M | 2.24% | 1,292,940 +502,740 | +64% | +$6.82M |
|
|
CPXX
14
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
| $15.6M | 1.99% | +1,414,114 | New | +$15.6M |
|
15
Neurogene
NGNE
$264M
| $14.9M | 1.91% | 1,691,977 +72,000 | +4% | +$635K |
|
16
Cidara Therapeutics
CDTX
$1.66B
| $14.9M | 1.91% | 1,174,219 | – | – |
|
17
Sangamo Therapeutics
SGMO
$157M
| $13.4M | 1.71% | 2,212,036 | – | – |
|
|
ACOR
18
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $13.2M | 1.68% | +498,159 | New | +$13.2M |
|
|
DRNA
19
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $13M | 1.66% | 2,428,571 | – | – |
|
20
Protara Therapeutics
TARA
$120M
| $12.6M | 1.61% | 1,626,931 +150,000 | +10% | +$1.16M |
|
|
SBBP
21
DELISTED
Strongbridge Biopharma plc.
SBBP
| $12.3M | 1.57% | 2,690,702 | – | – |
|
|
DMTX
22
DELISTED
Dimension Therapeutics, Inc
DMTX
| $12.1M | 1.55% | 1,548,033 +460,103 | +42% | +$3.6M |
|
23
Arcturus Therapeutics
ARCT
$462M
| $11.5M | 1.47% | 3,032,911 | – | – |
|
|
VTAE
24
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $10.4M | 1.33% | 1,575,000 +1,253,839 | +390% | +$8.31M |
|
|
25
Collegium Pharmaceutical
COLL
$1.22B
| $8.83M | 1.13% | 486,557 -371,126 | -43% | -$6.74M |
|